Cargando…
Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies
Previous epidemiological studies have raised the concern that the use of proton pump inhibitors (PPIs) is associated with an increased risk of kidney diseases. To date, no comprehensive meta-analysis has been conducted to assess the association between PPIs and the risk of chronic kidney disease (CK...
Autores principales: | Wu, Chieh-Chen, Liao, Mao-Hung, Kung, Woon-Man, Wang, Yao-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052387/ https://www.ncbi.nlm.nih.gov/pubmed/36983271 http://dx.doi.org/10.3390/jcm12062262 |
Ejemplares similares
-
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
por: Arora, Pradeep, et al.
Publicado: (2016) -
Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
por: Kweon, Takhyeon, et al.
Publicado: (2023) -
Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved
por: Thong, Benjamin Ka Seng, et al.
Publicado: (2019) -
Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies
por: Yang, Yi, et al.
Publicado: (2017) -
Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children
por: Li, Yanqin, et al.
Publicado: (2020)